Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Celanese Aktie: Umfassende Preiserhöhungen treiben Kurs an (Investing.com DE) +++ CELANESE Aktie +8,54%

AMGEN Aktie

 >AMGEN Aktienkurs 
349.05 EUR    +1.8%    (TradegateBSX)
Ask: 349.3 EUR / 220 Stück
Bid: 348.95 EUR / 220 Stück
Tagesumsatz: 1477 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
AMGEN Aktie über LYNX handeln
>AMGEN Performance
1 Woche: +3,7%
1 Monat: -8,8%
3 Monate: +16,7%
6 Monate: +14,7%
1 Jahr: +41,4%
laufendes Jahr: +22,2%
>AMGEN Aktie
Name:  AMGEN INC. DL-,0001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US0311621009 / 867900
Symbol/ Ticker:  AMG (Frankfurt) / AMGN (NASDAQ)
Kürzel:  FRA:AMG, ETR:AMG, AMG:GR, NASDAQ:AMGN
Profil:  Amgen Inc. is a global biotechnology company that discovers, develops, manufactures, and commercializes human therapeutics. Its current portfolio focuses on serious diseases across oncology, cardiovascular disease, inflammation, bone health, nephrolo..
>Volltext..
Marktkapitalisierung:  181532.6 Mio. EUR
Unternehmenswert:  219431.45 Mio. EUR
Umsatz:  33261.79 Mio. EUR
EBITDA:  15142.9 Mio. EUR
Nettogewinn:  7612.37 Mio. EUR
Gewinn je Aktie:  14.12 EUR
Schulden:  49893.56 Mio. EUR
Liquide Mittel:  12179.97 Mio. EUR
Operativer Cashflow:  10864.37 Mio. EUR
Bargeldquote:  0.55
Umsatzwachstum:  13.35%
Gewinnwachstum:  36.25%
Dividende je Aktie:  8.51 EUR
Dividendenrendite:  2.62%
Dividendenschätzung:  2.63%
Div. Historie:  21.08.26 - 2.157876€
15.05.26 - 2.1666958€
>weitere anzeigen...
Insiderhandel -
Suchwörter:  AMGEN
Letzte Datenerhebung:  22.09.26
>AMGEN Kennzahlen
Aktien/ Unternehmen:
Aktien: 540.63 Mio. St.
Frei handelbar: 99.77%
Rückkaufquote: -
Mitarbeiter: 31500
Umsatz/Mitarb.: 1.02 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 2.26%
Bewertung:
KGV: 23.77
KGV lG: 16.67
KUV: 5.43
KBV: 17.7
PEG-Ratio: 0.75
EV/EBITDA: 14.49
Rentabilität:
Bruttomarge: 72.71%
Gewinnmarge: 22.89%
Operative Marge: 33.31%
Managementeffizenz:
Gesamtkaprendite: 9.53%
Eigenkaprendite: 91.47%
 >AMGEN Anleihen 
>AMGEN Peer Group
Gesundheit, Onkologie/ Krebs- Behandlung, Herz-Kreislauf- Behandlung/ Kardiologie
 
22.09.26 - 15:54
Amgen Aktie steigt nach entscheidendem Studienerfolg bei Autoimmunerkrankung (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.09.26 - 15:48
Amgen Announces Positive Topline Phase 3 Results For Dazodalibep In Sjogren′s Disease (AFX)
 
THOUSAND OAKS (dpa-AFX) - Amgen, Inc. (AMGN) announced Tuesday positive topline results from the Phase 3 OASIZ 301 study evaluating dazodalibep in adults with Sjogren's disease and moderate-to-sev......
22.09.26 - 15:31
Amgen Aktie steigt nach positiven Studienergebnissen zum Sjögren-Syndrom (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.09.26 - 15:30
Amgen gains on late-stage trial win for Sjögren′s disease therapy (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.09.26 - 02:12
Morgan Stanley flags Amgen′s edge after heart-drug rival stumbles (The Street)
 
Morgan Stanley met with Amgen management after Novartis's pelacarsen trial failure. The bank sees a real edge for AMGN's olpasiran and MariTide....
21.09.26 - 20:30
Veeva Expands Amgen Partnership With Global Vault CRM Rollout Plan (Zacks)
 
VEEV expands its decade-long Amgen partnership with a global Vault CRM rollout, reinforcing enterprise adoption and commercial subscription growth....
19.09.26 - 15:00
Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story? (24/7 Wall St.)
 
Both Amgen and Merck write quarterly checks and raise them every year, but only one has the portfolio depth to keep growing that payout through the next brutal round of patent expirations. The answer may surprise investors who have been watching Merck's blockbuster momentum....
19.09.26 - 01:45
Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
 
In the most recent trading session, Amgen (AMGN) closed at $385.65, indicating a +1.55% shift from the previous trading day....
19.09.26 - 00:15
Top Research Reports for AMD, Linde & Amgen (Zacks)
 
AMD, Linde and Amgen highlight AI demand, contracted growth and drug launches, while supply, margin and pipeline risks remain key factors....
16.09.26 - 16:33
Sjögren′s Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2 Inhibitors, and Cell Therapies | DelveInsight (PR Newswire)
 
The Sjögren's syndrome market is undergoing a notable transformation, moving beyond traditional symptomatic management toward targeted immunomodulatory therapies. Emerging candidates, including Telitacicept (Vor Biopharma), Dazodalibep (Amgen), Nipocalimab (Johnson & Johnson),......
15.09.26 - 13:12
Leading Biotech Selects Veeva Vault CRM Globally (PR Newswire)
 
Agentic CRM foundation to help accelerate the delivery of innovative medicines to patients worldwide PLEASANTON, Calif., Sept. 15, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Amgen plans to deploy Veeva Vault CRM globally, building on a collaboration spanning more......
15.09.26 - 11:36
FDA reduces monitoring time for Amgen′s Imdelltra infusions (PBR)
 
The revised guidance is intended for adults whose ES-SCLC has progressed after treatment with platinum-based chemotherapy. It recommends a monitoring period ranging between six and eight hours in The post FDA reduces monitoring time for Amgen's Imdelltra infusions appeared first on Pharmaceutical Business review....
14.09.26 - 16:45
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)
 
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects....
14.09.26 - 15:48
Amgen: FDA Approves Update To IMDELLTRA Prescribing Information, Cuts Monitoring Time For Two Doses (AFX)
 
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) announced the FDA approved an update to the IMDELLTRA Prescribing Information that substantially reduces the recommended monitoring time for the first two do......
14.09.26 - 13:24
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? (Fool)
 
Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value and quality....
13.09.26 - 23:15
Trump says he plans to lift tariffs on Irish whiskey (The Hill)
 
President Trump said Sunday that he plans to lift tariffs on Irish whiskey, an announcement he made while visiting the Emerald Isle. “Ireland itself has been so incredible, so inviting, and we're very honored by presenting you with a great course. It's been great,” the president said while speaking at a ceremony for the Amgen......
13.09.26 - 22:06
Dunlop Sports Americas: Shane Lowry Claims Dominant Home Soil Victory at Amgen Irish Open (Accesswire)
 
HUNTINGTON BEACH, CA / ACCESS Newswire / September 13, 2026 / Srixon staffer Shane Lowry delivered a commanding performance at the Amgen Irish Open, capturing his first victory of the 2026 season a......
13.09.26 - 15:09
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.09.26 - 22:33
Chip stocks lead Nasdaq′s weekly gains; Amgen plunges after trial setback (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.09.26 - 18:00
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026? (Fool)
 
Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Werde nie so reich an Geist, dass arm Du würdest am Herzen! - Otto Ludwig
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!